Metacam

Negara: Uni Eropa

Bahasa: Inggris

Sumber: EMA (European Medicines Agency)

Beli Sekarang

Selebaran informasi Selebaran informasi (PIL)
14-01-2022
Karakteristik produk Karakteristik produk (SPC)
14-01-2022

Bahan aktif:

meloxicam

Tersedia dari:

Boehringer Ingelheim Vetmedica GmbH

Kode ATC:

QM01AC06

INN (Nama Internasional):

meloxicam

Kelompok Terapi:

Horses; Dogs; Cattle; Cats; Pigs; Guinea pigs

Area terapi:

Oxicams

Indikasi Terapi:

Cats:Alleviation of mild to moderate post-operative pain and inflammation following surgical procedures, e.g. orthopaedic and soft tissue surgery.Alleviation of pain and inflammation in acute and chronic musculo-skeletal disorders.Reduction of post-operative pain after ovariohysterectomy and minor soft tissue surgery.Cattle:For use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs.For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.For the relief of post-operative pain following dehorning in calves.For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.Dogs:Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders.Reduction of post-operative pain and inflammation following orthopaedic and soft tissue surgery.Horses:For use in the alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders.For the relief of pain associated with equine colic.Alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders.Pigs: For use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation.For the relief of post-operative pain associated with minor soft tissue surgery such as castration.For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.Guinea pigs:Alleviation of mild to moderate post-operative pain associated with soft tissues surgery such as male castration.

Ringkasan produk:

Revision: 27

Status otorisasi:

Authorised

Tanggal Otorisasi:

1998-01-07

Selebaran informasi

                                107
B. PACKAGE LEAFLET
108
PACKAGE LEAFLET:
METACAM 5 MG/ML SOLUTION FOR INJECTION FOR CATTLE AND PIGS
1.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF
THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
RELEASE, IF DIFFERENT
Marketing authorisation holder
Boehringer Ingelheim Vetmedica GmbH
55216 Ingelheim/Rhein
GERMANY
Manufacturer responsible for batch release
Labiana Life Sciences S.A.
Venus, 26
Can Parellada Industrial
08228 Terrassa, Barcelona
SPAIN
2.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Metacam 5 mg/ml solution for injection for cattle and pigs
Meloxicam
3.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENTS
One ml contains:
Meloxicam
5 mg
Ethanol
150 mg
Clear yellow solution.
4.
INDICATION(S)
Cattle:
For use in acute respiratory infection with appropriate antibiotic
therapy to reduce clinical signs in cattle.
For use in diarrhoea in combination with oral re-hydration therapy to
reduce clinical signs in calves of
over one week of age and young, non-lactating cattle.
For the relief of post-operative pain following dehorning in calves
.
Pigs:
For use in non-infectious locomotor disorders to reduce the symptoms
of lameness and inflammation.
For the relief of post operative pain associated with minor soft
tissue surgery such as castration.
5.
CONTRAINDICATIONS
Do not use in animals suffering from impaired hepatic, cardiac or
renal function and haemorrhagic
disorders, or where there is evidence of ulcerogenic gastrointestinal
lesions
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients.
For the treatment of diarrhoea in cattle, do not use in animals of
less than one week of age.
Do not use in pigs less than 2 days old.
109
6.
ADVERSE REACTIONS
In cattle, only a slight transient swelling at the injection site
following subcutaneous administration was
observed in less than 10 % of the cattle treated in clinical studies.
Anaphylactoid reactions, which may be serious (including fatal), have
been observed very rarely from
post-marketing safe
                                
                                Baca dokumen lengkapnya
                                
                            

Karakteristik produk

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Metacam 5
mg/ml solution for injection for cattle and pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One ml contains:
ACTIVE SUBSTANCE:
Meloxicam
5 mg
EXCIPIENT:
Ethanol
150 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear yellow solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle (calves and young cattle) and pigs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Cattle:
For use in acute respiratory infection with appropriate antibiotic
therapy to reduce clinical signs in cattle.
For use in diarrhoea in combination with oral re-hydration therapy to
reduce clinical signs in calves of
over one week of age and young, non-lactating cattle.
For the relief of post-operative pain following dehorning in calves.
Pigs:
For use in non-infectious locomotor disorders to reduce the symptoms
of lameness and inflammation.
For the relief of post-operative pain associated with minor soft
tissue surgery such as castration.
4.3
CONTRAINDICATIONS
Do not use in animals suffering from impaired hepatic, cardiac or
renal function and haemorrhagic
disorders, or where there is evidence of ulcerogenic gastrointestinal
lesions.
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients.
For the treatment of diarrhoea in cattle, do not use in animals of
less than one week of age.
Do not use in pigs less than 2 days old.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Treatment of calves with Metacam 20 minutes before dehorning reduces
post-operative pain. Metacam
alone will not provide adequate pain relief during the dehorning
procedure. To obtain adequate pain relief
during surgery co-medication with an appropriate analgesic is needed.
3
Treatment of piglets with Metacam before castration reduces
post-operative pain. To obtain pain relief
during surgery co-medication with an appropriate anaesthetic/sedative
is needed. To obtain the best
possible pain 
                                
                                Baca dokumen lengkapnya
                                
                            

Dokumen dalam bahasa lain

Selebaran informasi Selebaran informasi Bulgar 14-01-2022
Karakteristik produk Karakteristik produk Bulgar 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Bulgar 05-06-2018
Selebaran informasi Selebaran informasi Spanyol 14-01-2022
Karakteristik produk Karakteristik produk Spanyol 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Spanyol 05-06-2018
Selebaran informasi Selebaran informasi Cheska 14-01-2022
Karakteristik produk Karakteristik produk Cheska 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Cheska 05-06-2018
Selebaran informasi Selebaran informasi Dansk 14-01-2022
Karakteristik produk Karakteristik produk Dansk 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Dansk 05-06-2018
Selebaran informasi Selebaran informasi Jerman 14-01-2022
Karakteristik produk Karakteristik produk Jerman 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Jerman 05-06-2018
Selebaran informasi Selebaran informasi Esti 14-01-2022
Karakteristik produk Karakteristik produk Esti 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Esti 05-06-2018
Selebaran informasi Selebaran informasi Yunani 14-01-2022
Karakteristik produk Karakteristik produk Yunani 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Yunani 05-06-2018
Selebaran informasi Selebaran informasi Prancis 14-01-2022
Karakteristik produk Karakteristik produk Prancis 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Prancis 05-06-2018
Selebaran informasi Selebaran informasi Italia 14-01-2022
Karakteristik produk Karakteristik produk Italia 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Italia 05-06-2018
Selebaran informasi Selebaran informasi Latvi 14-01-2022
Karakteristik produk Karakteristik produk Latvi 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Latvi 05-06-2018
Selebaran informasi Selebaran informasi Lituavi 14-01-2022
Karakteristik produk Karakteristik produk Lituavi 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Lituavi 05-06-2018
Selebaran informasi Selebaran informasi Hungaria 14-01-2022
Karakteristik produk Karakteristik produk Hungaria 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Hungaria 05-06-2018
Selebaran informasi Selebaran informasi Malta 14-01-2022
Karakteristik produk Karakteristik produk Malta 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Malta 05-06-2018
Selebaran informasi Selebaran informasi Belanda 14-01-2022
Karakteristik produk Karakteristik produk Belanda 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Belanda 05-06-2018
Selebaran informasi Selebaran informasi Polski 14-01-2022
Karakteristik produk Karakteristik produk Polski 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Polski 05-06-2018
Selebaran informasi Selebaran informasi Portugis 14-01-2022
Karakteristik produk Karakteristik produk Portugis 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Portugis 05-06-2018
Selebaran informasi Selebaran informasi Rumania 14-01-2022
Karakteristik produk Karakteristik produk Rumania 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Rumania 05-06-2018
Selebaran informasi Selebaran informasi Slovak 14-01-2022
Karakteristik produk Karakteristik produk Slovak 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Slovak 05-06-2018
Selebaran informasi Selebaran informasi Sloven 14-01-2022
Karakteristik produk Karakteristik produk Sloven 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Sloven 05-06-2018
Selebaran informasi Selebaran informasi Suomi 14-01-2022
Karakteristik produk Karakteristik produk Suomi 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Suomi 05-06-2018
Selebaran informasi Selebaran informasi Swedia 14-01-2022
Karakteristik produk Karakteristik produk Swedia 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Swedia 05-06-2018
Selebaran informasi Selebaran informasi Norwegia 14-01-2022
Karakteristik produk Karakteristik produk Norwegia 14-01-2022
Selebaran informasi Selebaran informasi Islandia 14-01-2022
Karakteristik produk Karakteristik produk Islandia 14-01-2022
Selebaran informasi Selebaran informasi Kroasia 14-01-2022
Karakteristik produk Karakteristik produk Kroasia 14-01-2022
Laporan Penilaian publik Laporan Penilaian publik Kroasia 05-06-2018

Peringatan pencarian terkait dengan produk ini

Lihat riwayat dokumen